BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37004946)

  • 1. HOXD9 contributes to the Warburg effect and tumor metastasis in non-small cell lung cancer via transcriptional activation of PFKFB3.
    Wan K; Shao J; Liu X; Cai Y; Xu Y; Li L; Xiong L; Liang S
    Exp Cell Res; 2023 Jun; 427(1):113583. PubMed ID: 37004946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival.
    Lypova N; Telang S; Chesney J; Imbert-Fernandez Y
    J Biol Chem; 2019 Jul; 294(27):10530-10543. PubMed ID: 31126985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells.
    Xing J; Jia Z; Xu Y; Chen M; Yang Z; Chen Y; Han Y
    Bioengineered; 2021 Dec; 12(1):7563-7576. PubMed ID: 34612136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homeobox D9 drives the malignant phenotypes and enhances the Programmed death ligand-1 expression in non-small cell lung cancer cells via binding to Angiopoietin-2 promoter.
    He J; Jiang M; Liu J; Zhu R; Lv W; Lian R; Yang Y; Wang R
    World J Surg Oncol; 2023 Mar; 21(1):93. PubMed ID: 36907878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
    Li X; Liu J; Qian L; Ke H; Yao C; Tian W; Liu Y; Zhang J
    Mol Cell Biochem; 2018 Aug; 445(1-2):123-134. PubMed ID: 29327288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma.
    Thirusangu P; Ray U; Sarkar Bhattacharya S; Oien DB; Jin L; Staub J; Kannan N; Molina JR; Shridhar V
    Oncogene; 2022 Aug; 41(33):4003-4017. PubMed ID: 35804016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PFKFB3 Inhibition Impairs Erlotinib-Induced Autophagy in NSCLCs.
    Lypova N; Dougherty SM; Lanceta L; Chesney J; Imbert-Fernandez Y
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fascin promotes lung cancer growth and metastasis by enhancing glycolysis and PFKFB3 expression.
    Lin S; Li Y; Wang D; Huang C; Marino D; Bollt O; Wu C; Taylor MD; Li W; DeNicola GM; Hao J; Singh PK; Yang S
    Cancer Lett; 2021 Oct; 518():230-242. PubMed ID: 34303764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALK fusion promotes metabolic reprogramming of cancer cells by transcriptionally upregulating PFKFB3.
    Hu M; Bao R; Lin M; Han XR; Ai YJ; Gao Y; Guan KL; Xiong Y; Yuan HX
    Oncogene; 2022 Sep; 41(40):4547-4559. PubMed ID: 36064579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of PFKFB3 promotes cell glycolysis and proliferation in renal cell carcinoma.
    Li J; Zhang S; Liao D; Zhang Q; Chen C; Yang X; Jiang D; Pang J
    BMC Cancer; 2022 Jan; 22(1):83. PubMed ID: 35057732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
    O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
    Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes co-Loaded with 6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3 (PFKFB3) shRNA Plasmid and Docetaxel for the Treatment of non-small Cell Lung Cancer.
    Chowdhury N; Vhora I; Patel K; Doddapaneni R; Mondal A; Singh M
    Pharm Res; 2017 Nov; 34(11):2371-2384. PubMed ID: 28875330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of circ_0102273 inhibits the proliferation, metastasis and glycolysis of breast cancer through miR-1236-3p/PFKFB3 axis.
    Yu H; Luo H; Liu X
    Anticancer Drugs; 2022 Apr; 33(4):323-334. PubMed ID: 35266884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROCK2 promotes osteosarcoma growth and metastasis by modifying PFKFB3 ubiquitination and degradation.
    Deng X; Yi X; Deng J; Zou Y; Wang S; Shan W; Liu P; Zhang Z; Chen L; Hao L
    Exp Cell Res; 2019 Dec; 385(2):111689. PubMed ID: 31678169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT/mTOR signaling pathway in non-small cell lung cancer.
    Li J; Cheng D; Zhu M; Yu H; Pan Z; Liu L; Geng Q; Pan H; Yan M; Yao M
    Theranostics; 2019; 9(1):179-195. PubMed ID: 30662561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer.
    Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T
    Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shikonin inhibits the Warburg effect, cell proliferation, invasion and migration by downregulating PFKFB2 expression in lung cancer.
    Sha L; Lv Z; Liu Y; Zhang Y; Sui X; Wang T; Zhang H
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA LINC00930 promotes PFKFB3-mediated tumor glycolysis and cell proliferation in nasopharyngeal carcinoma.
    He B; Pan H; Zheng F; Chen S; Bie Q; Cao J; Zhao R; Liang J; Wei L; Zeng J; Li H; Cui X; Ding Y; Chao W; Xiang T; Cheng Y; Qiu G; Huang S; Tang L; Chang J; Luo D; Yang J; Zhang B
    J Exp Clin Cancer Res; 2022 Feb; 41(1):77. PubMed ID: 35209949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis.
    Mejias M; Gallego J; Naranjo-Suarez S; Ramirez M; Pell N; Manzano A; Suñer C; Bartrons R; Mendez R; Fernandez M
    Gastroenterology; 2020 Jul; 159(1):273-288. PubMed ID: 32169429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of PFKFB3 with miR-206 but not mir-26b inhibits ovarian cancer cell proliferation and migration involving FAK downregulation.
    Boscaro C; Baggio C; Carotti M; Sandonà D; Trevisi L; Cignarella A; Bolego C
    FASEB J; 2022 Mar; 36(3):e22140. PubMed ID: 35107852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.